Keywords: fda, toughens, warnings, gw, lotronex, first, rx

FDA toughens warnings on GW's Lotronex, first Rx drug to carry side effect

Article | 25 August 2000

Print This

The US Food and Drug Administration says it is to strengthen thewarnings on Glaxo Wellcome's irritable bowel syndrome therapy Lotronex ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in